QuantOCancer ERA Chair @ Champalimaud Foundation

Deciding how to fund research: 

perspectives on the partial randomisation process

Wednesday 21st September 2022

Online

As competition for research funding increases, funding agencies are looking for novel ways to allocate their funds in a bid to remove potential biases and increase the transparency of how funding decisions are made. 

The overall goal of this event is to highlight examples from international funding entities that are either already piloting or considering implementing different models to allocate research funds, with a particular emphasis on the partial randomisation process, and highlight the perspective of researchers on this topic. The session will end with a roundtable discussion featuring the views from researchers hosted by Portuguese institutions on whether partial randomisation is an appropriate alternative to the current peer review process.  

Preliminary Agenda 

21st September 2022  Time (WEST) 

9.30 - 9.45 am

Opening remarks, Champalimaud Foundation/Champalimaud Research

9.45 - 10.15 am

Marco Bieri, Scientific Officer, Swiss National Science Foundation

10.15 - 10.45 am

Lene Oddershede, Senior Vice President, Novo Nordisk Foundation

10.45 - 11.15 am 

Axel Philipps, Leibniz Center for Science and Society, Leibniz University of Hannover

11.15 - 11.30 Comfort break

11.30 - 12.00 pm 

Adrian Mota, Associate Vice-President, Research Programs - Operations, Canadian Institutes of Health Research

12.00 - 1.15 pm 

Roundtable discussion: COLife Researchers views on partial randomisation for the allocation of research funding 

Moderated by Adriana Sánchez-Danés, Champalimaud Foundation

Using Format